Brigit Biofarmaka Teknologi Tbk. vs RDI Insight ETF FTSE Indonesia Low Volatility Factor Index — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 45.1K 24h volume), while RDI Insight ETF FTSE Indonesia Low Volatility Factor Index trades at Rp100 (market cap 2.12B, 100K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 77.7× RDI Insight ETF FTSE Indonesia Low Volatility Factor Index's market cap, and RDI Insight ETF FTSE Indonesia Low Volatility Factor Index is more actively traded (100K versus 45.1K). Which is the better fit depends on your goals.
| OBAT | XILV | |
|---|---|---|
Market Cap | 164.65B | 2.12B |
Volume | 45.1K | 100K |
Lot | 451 | 1K |
Turnover | 10.89M | 10M |
Average Price | 241.39 | 100 |
Value | 10.89M | 10M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →